Now World View
61
China’s modified virus therapy shows promise in last-stage cancer trials
A new cancer therapy utilising a genetically modified herpes simplex virus type 1 (HSV-1) offers hope for late-stage patients, especially those resistant to existing immunotherapies.
Representational Image
Was this article helpful?
Yes0No0
Discover more from Now World View
Subscribe to get the latest posts sent to your email.